Paysign (NASDAQ:PAYS) Issues Quarterly Earnings Results

Key Points

• Paysign reported earnings of $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.04 EPS by $0.02.
• The stock saw a 0.6% decline during midday trading, reaching a price of $7.12 with a market capitalization of $386.05 million.
• Insider selling activity included CFO and CEO transactions, with the CFO selling 30,396 shares and the CEO selling 62,158 shares, indicating a decrease in their ownership percentages.

Paysign (NASDAQ:PAYS - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.02), Zacks reports. Paysign had a net margin of 9.90% and a return on equity of 19.32%. The firm had revenue of $19.08 million for the quarter, compared to analysts' expectations of $18.69 million. Paysign updated its Q3 2025 guidance to EPS and its FY 2025 guidance to 0.100-0.120 EPS.

Paysign Stock Performance

Shares of Paysign stock traded down $0.28 on Friday, hitting $5.61. 1,282,804 shares of the company's stock were exchanged, compared to its average volume of 1,028,210. The company has a 50-day simple moving average of $6.66 and a 200-day simple moving average of $4.02. The stock has a market capitalization of $305.46 million, a PE ratio of 46.75 and a beta of 0.78. Paysign has a 1 year low of $1.80 and a 1 year high of $8.88.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on PAYS shares. LADENBURG THALM/SH SH raised their target price on shares of Paysign from $7.25 to $8.25 and gave the stock a "buy" rating in a report on Friday, May 9th. DA Davidson set a $9.00 target price on shares of Paysign in a report on Thursday. Finally, Lake Street Capital raised their target price on shares of Paysign from $9.00 to $10.00 and gave the stock a "buy" rating in a report on Wednesday.

Insider Activity

In other news, insider Robert Strobo sold 26,521 shares of the firm's stock in a transaction on Monday, August 4th. The shares were sold at an average price of $7.09, for a total transaction of $188,033.89. Following the sale, the insider directly owned 247,290 shares in the company, valued at $1,753,286.10. This trade represents a 9.69% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Jeffery Bradford Baker sold 30,396 shares of the firm's stock in a transaction on Monday, August 4th. The shares were sold at an average price of $7.09, for a total transaction of $215,507.64. Following the sale, the chief financial officer owned 252,273 shares in the company, valued at $1,788,615.57. The trade was a 10.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 433,602 shares of company stock worth $2,409,455. 22.40% of the stock is currently owned by insiders.

Institutional Trading of Paysign

Institutional investors and hedge funds have recently modified their holdings of the company. Jane Street Group LLC bought a new stake in Paysign in the 1st quarter valued at $51,000. Rhumbline Advisers grew its stake in shares of Paysign by 5.2% in the 1st quarter. Rhumbline Advisers now owns 46,587 shares of the company's stock worth $99,000 after buying an additional 2,303 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Paysign by 7.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 258,334 shares of the company's stock worth $548,000 after buying an additional 17,466 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Paysign by 1.6% during the 2nd quarter. Geode Capital Management LLC now owns 788,500 shares of the company's stock worth $5,679,000 after purchasing an additional 12,490 shares during the period. 25.89% of the stock is currently owned by institutional investors.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.